| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |